A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Clinical trial NCT05301517 · COMPLETED
Trial details
- NCT number
- NCT05301517
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2023-04-03
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.